Julie A Patterson
Biographic Data
| ID | 7076142 |
|---|---|
| NAME | Julie A Patterson |
| GIVEN NAMES | Julie A |
| FAMILY NAME | Patterson |
| SIGNATURE | PATTERSON J A |
| AFFILIATIONS | National Pharmaceutical Council, Washington, DC, USA |
| ORCID | 0000-0002-0602-3882 |
| VERIFIED | Yes |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 5 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 1952 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
The Association of 340B Program Drug Margins with Covered Entity Characteristics
The 340B Drug Pricing Program aims to help facilities serving low-income and uninsured patients to stretch scarce resources by allowing covered entities to purchase outpatient drugs at federally mandated discounted rates while often receiving reimbursement for them at higher rates by commercial payers and Medicare. Despite increasing focus on the expansion and impact of the program, profit margins under 340B have not been fully explored. We aimed…
Medicare Part D Coverage of Drugs Selected for the Drug Price Negotiation Program
This cross-sectional study describes and historically benchmarks Medicare Part D coverage in 2019 and 2023 for the first 10 drugs selected for negotiation
Pain, Substance Use Disorders, Mental Health, and Buprenorphine Treatment among Patients With and Without HIV
Treatment of opioid use disorder (OUD) with buprenorphine improves outcomes and mortality among people with HIV (PWH). However, engagement is low and is influenced by comorbidities. We examined the impact of patterns of co-occurring pain, substance use disorders (SUDs), and mental health diagnoses on buprenorphine initiation and retention in PWH. The Veterans Aging Cohort Study contained 7,875 patients (2,702 PWH and 5,173 without HIV) with new O…
Can a regional government's social inclusion initiative contribute to the quest for health equity?
Despite decades of concern about reducing health inequity, the Commission on the Social Determinants of Health (CSDH) painted a picture of persistent and, in some cases, increasing health inequity. It also made a call for increased evaluation of interventions that might reduce inequities. This paper describes such an intervention-the Social Inclusion Initiative (SII) of the South Australian Government-that was documented for the Social Exclusion …
Some Impressions of the Fifth World Health Assembly
No prominent works on this page.
Some Impressions of the Fifth World Health Assembly
Can a regional government's social inclusion initiative contribute to the quest for health equity?
Despite decades of concern about reducing health inequity, the Commission on the Social Determinants of Health (CSDH) painted a picture of persistent and, in some cases, increasing health inequity. It also made a call for increased evaluation of interventions that might reduce inequities. This paper describes such an intervention-the Social Inclusion Initiative (SII) of the South Australian Government-that was documented for the Social Exclusion …
Medicare Part D Coverage of Drugs Selected for the Drug Price Negotiation Program
This cross-sectional study describes and historically benchmarks Medicare Part D coverage in 2019 and 2023 for the first 10 drugs selected for negotiation
Pain, Substance Use Disorders, Mental Health, and Buprenorphine Treatment among Patients With and Without HIV
Treatment of opioid use disorder (OUD) with buprenorphine improves outcomes and mortality among people with HIV (PWH). However, engagement is low and is influenced by comorbidities. We examined the impact of patterns of co-occurring pain, substance use disorders (SUDs), and mental health diagnoses on buprenorphine initiation and retention in PWH. The Veterans Aging Cohort Study contained 7,875 patients (2,702 PWH and 5,173 without HIV) with new O…
The Association of 340B Program Drug Margins with Covered Entity Characteristics
The 340B Drug Pricing Program aims to help facilities serving low-income and uninsured patients to stretch scarce resources by allowing covered entities to purchase outpatient drugs at federally mandated discounted rates while often receiving reimbursement for them at higher rates by commercial payers and Medicare. Despite increasing focus on the expansion and impact of the program, profit margins under 340B have not been fully explored. We aimed…
Medicine (4 works) · Business (2 works) · Economic growth (2 works) · Economics (2 works) · Health care (2 works) · Health Systems, Economic Evaluations, Quality of Life (2 works) · Healthcare Policy and Management (2 works) · Political science (2 works) · Actuarial science (1 work) · Buprenorphine (1 work)